EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy

Daria Vinokurova, Lionel Apetoh iD

Biomolecules · 2023

DOI: 10.3390/biom13040670 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Daria Vinokurova und 1 weiteren Autor:innen. Beteiligte Einrichtung: UMR 1231, Lipides Nutrition Cancer, INSERM, 21000 Dijon, France. Hauptthemen laut MEDLINE: Interleukin-9, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Fondation de France, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PD-1 blockade rescues failing anticancer immune responses, resulting in durable remissions in some cancer patients. Cytokines such as IFNγ and IL-2 contribute to the anti-tumor effect of PD-1 blockade. IL-9 was identified over the last decade as a cytokine demonstrating a potent ability to harness the anticancer functions of innate and adaptive immune cells in mice. Recent translational investigations suggest that the anticancer activity of IL-9 also extends to some human cancers. Increased T cell-derived IL-9 was proposed to predict the response to anti-PD-1 therapy. Preclinical investigations accordingly revealed that IL-9 could synergize with anti-PD-1 therapy in eliciting anticancer responses. Here, we review the findings suggesting an important contribution of IL-9 in the efficacy of anti-PD-1 therapy and discuss their clinical relevance. We will also discuss the role of host factors like the microbiota and TGFβ in the tumor microenvironment (TME) in the regulation of IL-9 secretion and anti-PD-1 treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-9NeoplasmsHumansAnimalsMiceCytokinesImmunotherapyT-LymphocytesTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

TH9 cellsanti-PD-1cancer immunotherapyinterleukin 9

Substanzen

Interleukin-9Cytokines

Autor:innen und Institutionen

  • UMR 1231, Lipides Nutrition Cancer, INSERM, 21000 Dijon, France.
  • UFR des Sciences de Santé, Université de Bourgogne, 21000 Dijon, France.
  • Brown Center for Immunotherapy, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

ORCID-Profile: Lionel Apetoh

Förderung

  • European Research Council
  • Fondation de France
  • Fondation pour la Recherche Médicale
  • Conseil Régional de Bourgogne
  • FEDER
  • LabEx LipSTIC
  • LabEx MAbImprove
  • Brown Center for Immunotherapy at Indiana University Melvin

Zitieren

APA

Vinokurova, D., & Apetoh, L. (2023). The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy. Biomolecules. https://doi.org/10.3390/biom13040670

Vancouver

Vinokurova D, Apetoh L. The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy. Biomolecules. 2023. doi:10.3390/biom13040670

BibTeX
@article{Vinokurova2023,
  author = {Vinokurova, Daria and Apetoh, Lionel},
  title = {The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13040670}
}
Kostenlos starten →